Terms: = Testicular cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679 AND Treatment
6 results:
1. Two decades of FDG-PET/CT in seminoma: exploring its role in diagnosis, surveillance and follow-up.
Conduit C; Koh TT; Hofman MS; Toner GC; Goad J; Lawrentschuk N; Tai KH; Lewin JH; Tran B
Cancer Imaging; 2022 Oct; 22(1):58. PubMed ID: 36209121
[TBL] [Abstract] [Full Text] [Related]
2. Retrospective analysis of patients with relapsed or refractory testicular nonseminous germ cell tumors treated with autologous stem cell transplantation.
Yilmaz F; Soyer N; Uslu R; Erdogan AP; Karaca B; Saydam G; Sahin F; Vural F
Indian J Cancer; 2017; 54(2):415-420. PubMed ID: 29469069
[TBL] [Abstract] [Full Text] [Related]
3. Phase I study of PD 0332991, a cyclin-dependent kinase inhibitor, administered in 3-week cycles (Schedule 2/1).
Schwartz GK; LoRusso PM; Dickson MA; Randolph SS; Shaik MN; Wilner KD; Courtney R; O'Dwyer PJ
Br J Cancer; 2011 Jun; 104(12):1862-8. PubMed ID: 21610706
[TBL] [Abstract] [Full Text] [Related]
4. Testosterone production is better preserved after 16 than 20 Gray irradiation treatment against testicular carcinoma in situ cells.
Bang AK; Petersen JH; Petersen PM; Andersson AM; Daugaard G; Jørgensen N
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):672-6. PubMed ID: 19250763
[TBL] [Abstract] [Full Text] [Related]
5. Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: a prospective trial (MRC TE17).
Dearnaley DP; Fossa SD; Kaye SB; Cullen MH; Harland SJ; Sokal MP; Graham JD; Roberts JT; Mead GM; Williams MV; Cook PA; Stenning SP;
Br J Cancer; 2005 Jun; 92(12):2107-13. PubMed ID: 15928672
[TBL] [Abstract] [Full Text] [Related]
6. [In vivo and in vitro effects of GnRH analogs on ovarian Leydig cell tumor].
Emons G; Ortmann O; Pahwa GS; Löhrs U; Wetterling T; Dilling H; Oberheuser F; Knuppen R
Geburtshilfe Frauenheilkd; 1992 Aug; 52(8):487-93. PubMed ID: 1327941
[TBL] [Abstract] [Full Text] [Related]
